Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2022
- Accession no.
- 0000899243-22-008109
- Filed
- Feb 28, 2022
- Trade date
- Feb 24-25, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $1.75M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2022 | Common Stock | FTax withholdingDisposed | −6,038 | $227.86 | −$1,375,818.68 | 43,649 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −1,040 | $229.41F2,F3 | −$238,586.4 | 42,609 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −3,188 | $230.62F3,F4 | −$735,216.56 | 39,421 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −2,784 | $231.64F3,F5 | −$644,885.76 | 36,637 | Direct | |
| Feb 25, 2022 | Common Stock | SSaleDisposed | −560 | $232.68F3,F6 | −$130,300.8 | 36,077 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Open market sales reported on this line occurred at a weighted average price of $229.41 (range $228.91 to $229.81).
Referenced by the price of 1 transaction in Table I.
- F3
Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 4 transactions in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $230.62 (range $230.07 to $231.05).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $231.64 (range $231.08 to $232.07).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $232.68 (range $232.43 to $232.87).
Referenced by the price of 1 transaction in Table I.